| Financial Year |
March 31 2023 |
| Monetary Funds |
791,976,347.54 |
| Held-for-trading Financial Assets |
2,963.26 |
| Notes Receivable |
-- |
| Accounts Receivable |
392,430,108.62 |
| Advances to Suppliers |
9,123,622.92 |
| Other Receivables |
204,241,058.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
366,970,108.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,602,960.70 |
| Total Current Assets |
1,772,612,463.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
436,934,314.88 |
| Under-construction Projects |
4,238,455.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
206,196,809.93 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
153,697,304.89 |
| Deferred Income Tax Assets |
84,469,831.15 |
| Other Non-Current Assets |
2,811,427.68 |
| Sub-Total of Non-Current Assets |
1,044,841,719.80 |
| Total Assets |
2,817,454,183.29 |
| Short-Term Loans |
234,836,396.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
120,000,000.00 |
| Accounts Payable |
229,616,912.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,043,405.41 |
| Taxes Payable |
14,605,951.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,756,916.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
188,808,044.94 |
| Other Current Liabilities |
3,480,088.63 |
| Sub-Total of Current Liabilities |
923,442,631.88 |
| Long-term Loans |
398,468,115.86 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,022,596.38 |
| Deferred Income Tax Liabilities |
15,173,632.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
561,225,516.22 |
| Total Liabilities |
1,484,668,148.10 |
| Paid-In Capital(Or Share Stock) |
516,580,886.00 |
| Capital Surplus |
1,162,433,601.49 |
| Surplus Reserve |
124,721,262.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-474,082,578.69 |
| Minority Stockholder's Interest |
2,194,315.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,330,591,719.35 |
| Owner's Equity（Stockholder's Equity） |
1,332,786,035.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,817,454,183.29 |
